7MM Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease Market Opportunity Assessment and Forecasts 2024-2034 [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
Significant unmet needs and emerging pipeline products present avenues for market expansion and strategic partnerships, particularly in innovative therapies and competitive positioning. Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease: Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM (US, 5EU, Japan) and provides an Excel-based forecast model for the CKD-HPT, HP and HK market through 2034. There will be an overall increase in the diagnosed prevalent cases of CKD- HPT, HP and HK in the 7MM across the forecast period. Across the 7MM, the mainstay treatment for HPT, HP, and HK involves phosphate binders, calcimimetics, and potassium binders Significant clinical and environmental unmet needs remain in the CKD- HPT, HP and HK market. The Combined sales for CKD-HPT, HP, and HK are expected to grow modestly over the forecast perio
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns [Yahoo! Finance]Yahoo! Finance
- AI genome sequencing could transform rare disease diagnosis: GeneDx CEO [FOX Business Network]FOX Business Network
- Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance [Yahoo! Finance]Yahoo! Finance
- GeneDx Announces GenomeDx Prenatalâ„¢, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care [Yahoo! Finance]Yahoo! Finance
- OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
OPK
Earnings
- 10/29/25 - Beat
OPK
Sec Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 4
- 11/19/25 - Form 4
- OPK's page on the SEC website